Cross‐Cohort Transcriptomic and Oral Microbiome Analyses Identify Ferroptosis‐Associated Signatures in Periodontitis and Oral Squamous Cell Carcinoma
- 1Department of Stomatology Affiliated People′s Hospital of Jiangsu University Zhenjiang City Jiangsu Province China
Abstract
Background: Periodontitis (PD) and oral squamous cell carcinoma (OSCC) have been investigated in relation to inflammation, oral microbial alterations, and iron/redox biology. Whether ferroptosis‐associated expression patterns overlap across independently sampled periodontal and cancer cohorts remains uncertain. We characterized these patterns without presuming that the available datasets represent matched individuals or a temporal disease sequence.
Methods: We analyzed gingival single‐cell RNA‐sequencing data (GSE171213), an OSCC discovery expression cohort (GSE30784), and an independent oral tongue squamous cell carcinoma validation cohort (GSE13601). Periodontal microbial functional gene profiles (GSE54290) and a cross‐study OSCC 16S abundance resource were examined separately. Analyses included cell annotation, KEGG ferroptosis gene‐set scoring, sample‐ and cell type‐level comparisons, differential expression, external transcriptomic signature validation, microbial diversity and abundance analyses, and LPS‐stimulated cell‐line RT‐qPCR and ELISA measurements. The transcriptomic and microbial cohorts were not linked at the individual‐patient level.
Results: Quality control retained 34,342 cells from 12 gingival samples (four healthy controls [HCs], five PD, and three treated periodontitis [PDT]), assigned to 11 annotated cell populations. Mean sample‐level ferroptosis gene‐set scores were 0.081 in HC, 0.114 in PD, and 0.076 in PDT; these descriptive scores do not measure ferroptotic cell death. SAT1 showed a positive PD‐versus‐HC association in cell type pseudobulk analysis (log2 fold change, 0.546; false discovery rate [FDR], 0.012) and positive effects across all three transcriptomic cohorts. A discovery‐derived ferroptosis‐associated OSCC signature achieved an area under the receiver operating characteristic curve of 0.933 in GSE13601. Periodontal functional profiling identified 25 advanced PD‐associated annotations (FDR < 0.05), including lower ferrochelatase signals. Cross‐study OSCC microbiome analysis found 293 diagnosis‐associated features after project adjustment; project‐held‐out classification yielded an AUC of 0.674. Following lipopolysaccharide stimulation, GPX4, SLC7A11, and FTH1 increased and ACSL4 decreased at the measured mRNA and protein levels in gingival fibroblasts and THP‐1‐derived macrophages.
Conclusions: Independently sampled periodontal and OSCC cohorts show ferroptosis‐associated transcriptomic changes, with SAT1 emerging as a cross‐cohort candidate. Parallel microbial datasets identify disease‐associated functional gene and taxonomic differences but do not demonstrate within‐patient host–microbe interactions or causal mediation. LPS‐exposed cell‐line measurements show expression changes in selected ferroptosis‐associated markers, not ferroptotic cell death or functional resistance. The results are exploratory associations; in the absence of direct ferroptosis assays, paired longitudinal cohorts, and prospective clinical validation, they cannot establish a disease‐progression mechanism, clinically deployable biomarker or therapeutic efficacy.
Related
- Primary-Tumor Transcriptomic Signatures Associated with Circulating Tumor Cells Status in Breast Cancer: From CTC-Negative Remodeling to CTC-Associated Metastatic Programs
- Nicotinamide Mononucleotide Is Associated with Attenuation of OGD/R-Induced Pro-Inflammatory Programs in Microglia: Transcriptomic Evidence Converging on the NLRP3 Inflammasome and Lipid-Droplet-Related Molecular Signatures
- Transcriptomic Profiling of Oxidative Stress-Associated Immune and Apoptotic Signatures and In Silico Prediction of Therapeutic Candidates for Sjögren’s Syndrome Dry Eye
- Nutrition-related lipid metabolism and ferroptosis in endometrial cancer: transcriptomic profiling and hypoxia-associated gene expression
- Paired biopsy-surface and tissue microbiome profiling reveals tissue-associated bacterial signatures in nasopharyngeal carcinoma.
BibTeX
@article{qiu2026crosscohort,
title = {{Cross‐Cohort Transcriptomic and Oral Microbiome Analyses Identify Ferroptosis‐Associated Signatures in Periodontitis and Oral Squamous Cell Carcinoma}},
author = {Chenguang Qiu and Peng She and Lin Wu},
journal = {International Journal of Genomics},
year = {2026},
month = nov,
doi = {10.1155/ijog/7538825},
url = {https://doi.org/10.1155/ijog/7538825},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Cross‐Cohort Transcriptomic and Oral Microbiome Analyses Identify Ferroptosis‐Associated Signatures in Periodontitis and Oral Squamous Cell Carcinoma
AU - Chenguang Qiu
AU - Peng She
AU - Lin Wu
PY - 2026
DA - 2026/11/03
JO - International Journal of Genomics
DO - 10.1155/ijog/7538825
UR - https://doi.org/10.1155/ijog/7538825
AB - Background: Periodontitis (PD) and oral squamous cell carcinoma (OSCC) have been investigated in relation to inflammation, oral microbial alterations, and iron/redox biology. Whether ferroptosis‐associated expression patterns overlap across independently sampled periodontal and cancer cohorts remains uncertain. We characterized these patterns without presuming that the available datasets represent matched individuals or a temporal disease sequence. Methods: We analyzed gingival single‐cell RNA‐sequencing data (GSE171213), an OSCC discovery expression cohort (GSE30784), and an independent oral tongue squamous cell carcinoma validation cohort (GSE13601). Periodontal microbial functional gene profiles (GSE54290) and a cross‐study OSCC 16S abundance resource were examined separately. Analyses included cell annotation, KEGG ferroptosis gene‐set scoring, sample‐ and cell type‐level comparisons, differential expression, external transcriptomic signature validation, microbial diversity and abundance analyses, and LPS‐stimulated cell‐line RT‐qPCR and ELISA measurements. The transcriptomic and microbial cohorts were not linked at the individual‐patient level. Results: Quality control retained 34,342 cells from 12 gingival samples (four healthy controls [HCs], five PD, and three treated periodontitis [PDT]), assigned to 11 annotated cell populations. Mean sample‐level ferroptosis gene‐set scores were 0.081 in HC, 0.114 in PD, and 0.076 in PDT; these descriptive scores do not measure ferroptotic cell death. SAT1 showed a positive PD‐versus‐HC association in cell type pseudobulk analysis (log2 fold change, 0.546; false discovery rate [FDR], 0.012) and positive effects across all three transcriptomic cohorts. A discovery‐derived ferroptosis‐associated OSCC signature achieved an area under the receiver operating characteristic curve of 0.933 in GSE13601. Periodontal functional profiling identified 25 advanced PD‐associated annotations (FDR < 0.05), including lower ferrochelatase signals. Cross‐study OSCC microbiome analysis found 293 diagnosis‐associated features after project adjustment; project‐held‐out classification yielded an AUC of 0.674. Following lipopolysaccharide stimulation, GPX4, SLC7A11, and FTH1 increased and ACSL4 decreased at the measured mRNA and protein levels in gingival fibroblasts and THP‐1‐derived macrophages. Conclusions: Independently sampled periodontal and OSCC cohorts show ferroptosis‐associated transcriptomic changes, with SAT1 emerging as a cross‐cohort candidate. Parallel microbial datasets identify disease‐associated functional gene and taxonomic differences but do not demonstrate within‐patient host–microbe interactions or causal mediation. LPS‐exposed cell‐line measurements show expression changes in selected ferroptosis‐associated markers, not ferroptotic cell death or functional resistance. The results are exploratory associations; in the absence of direct ferroptosis assays, paired longitudinal cohorts, and prospective clinical validation, they cannot establish a disease‐progression mechanism, clinically deployable biomarker or therapeutic efficacy.
SN - 2314-436X
SN - 2314-4378
ER -